Elite Pharma Inc (ELTP) earnings · rev $148.9M
Elite Pharma Inc (ELTP) is a drug manufacturers - specialty & generic company listed on US.
This ELTP earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ELTP revenue for 2026-03-31 was $148.9M. Net income was $44.9M. Revenue was up 77.1% from 2025-03-31 to 2026-03-31. ELTP currently screens at market cap $659.0M.
When the next ELTP 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 77.1% from 2025-03-31 to 2026-03-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ELTP research stays on the stock page; the tape stays on the quote page.
Not investment advice.